据ICIS网站8月16日消息 泰国化工巨头Indorama周一表示，将以13亿美元收购巴西表面活性剂生产商Oxiteno，后者为Ultrapar子公司。
根据监管部门的批准，该交易预计将于2022年第一季度完成。
Indorama同意将一笔1.5亿美元的付款推迟至2024年，收购价格为13亿美元。
Oxiteno在巴西、墨西哥、美国和乌拉圭拥有11个子单位。在阿根廷、比利时、中国和哥伦比亚设有两个全球研发中心、三个研发设施和八个商业办事处。
Oxiteno于1973年在巴西国内市场成立，在Suzano和Tremenbe（圣保罗州）、Triunfo（南里奥格兰德州）、Maua石化枢纽（圣保罗州）和Camacari工业枢纽（巴伊亚州）设有工厂。
就在上周，Ultrapar首席执行官表示，与Indorama的销售谈判进展顺利。通过最近的收购，Indorama继续其在美洲的扩张。在美洲，已成为该大陆的主要化学参与者之一。
王磊 摘译自 ICIS
原文如下：
Indorama to acquire Brazil’s Oxiteno for $1.3bn
Indorama is to acquire Brazil’s surfactants producer Oxiteno, subsidiary of Ultrapar, for $1.3bn, the Thai chemicals major said align="justify"> Subject to regulatory approvals, the transaction is expected to close in the first quarter of 2022.
Indorama agreed to defer align="justify"> Oxiteno has 11 industrial units in Brazil, Mexico, the US, and Uruguay; two global R&D centres, three R&D facilities, and eight commercial offices in Argentina, Belgium, China, and Colombia.
In Brazil, its domestic market where it was founded in 1973, Oxiteno has plants in Suzano and Tremembe (Sao Paulo state), Triunfo (Rio Grande do Sul state), the Petrochemical Hub of Maua (also Sao Paulo state) and the Industrial Hub of Camacari (Bahia state).
Just last week, Ultrapar’s CEO said talks with Indorama for the sale were well advanced; with its latest acquisition, Indorama continues its expansion in the Americas, where it has become one of the key chemical players in the continent.